Concerns growing over domestic market entry of leading generic companies

Korean pharmaceutical firms are jittery over possible entry of leading foreign companies, such as Cipla Limited and Teva.

Cipla Limited is looking to seek Korean partners to market their hundreds of generic medications it produces here in Korea.

Cipla is a prominent Indian pharmaceutical company, best-known outside its home country for producing low-cost anti-AIDS drugs for HIV-positive p...